Aquestive Therapeutics Stock Surges 43% Over Complete Response Letter From FDA For Anaphylm NDA
RTTNews· 2026-02-02 16:39
Stock of Aquestive Therapeutics, Inc. (AQST) is soaring about 43 percent on Monday morning trading following its announcement about a Complete Response Letter received from the FDA for the New Drug Application seeking approval of Anaphylm Sublingual Film for the treatment of Type I allergic reactions.Currently, AQST is trading at $4.22, up 42.98 percent, over the previous close of $2.95. The stock opened at $3.79 and has climbed as high as $4.39 so far in today's session. Over the past year, it has traded ...
Kevin Warsh 'hurts Fed independence,' says 3Fourteen's Warren Pies
Youtube· 2026-02-02 16:39
Not everyone though is a fan of the president's pick. 314 Research co-founder Warren Pi is writing on X that Kevin Warsh was the worst pick of the four candidates and will not garner trust from the market. Warren joins us this morning to talk more about that.Warren, appreciate the time as always. Good to see you. >> Good to see you.>> Uh you're not alone either. I think Ren Mack has been fairly critical. What do you think is the problem with this pick.Yeah, I I as I laid out there, I think that he is workin ...
Baidu: A Dividend Giant In The Making (NASDAQ:BIDU)
Seeking Alpha· 2026-02-02 16:39
Baidu, Inc. ( BIDU ) stock is nowhere near the highs of $330+ seen in early 2021. However, BIDU stock has made a strong comeback in the past 12 months (up 61%). Last November, ahead of Baidu’s Q3 earnings,Dilantha De Silva is an experienced equity analyst and investment researcher with over 10 years in the investment industry. He writes insightful articles for Seeking Alpha, GuruFocus, TipRanks, and ValueWalk, with a significant following on Seeking Alpha. Dilantha’s expertise spans across various sectors, ...
Baidu: A Dividend Giant In The Making

Seeking Alpha· 2026-02-02 16:39
Baidu, Inc. ( BIDU ) stock is nowhere near the highs of $330+ seen in early 2021. However, BIDU stock has made a strong comeback in the past 12 months (up 61%). Last November, ahead of Baidu’s Q3 earnings,Dilantha De Silva is an experienced equity analyst and investment researcher with over 10 years in the investment industry. He writes insightful articles for Seeking Alpha, GuruFocus, TipRanks, and ValueWalk, with a significant following on Seeking Alpha. Dilantha’s expertise spans across various sectors, ...
AIGH Capital Dumps 1.1 Million MaxLinear (MXL) Shares
Yahoo Finance· 2026-02-02 16:38
On February 2, 2026, AIGH Capital Management LLC fully exited its stake in MaxLinear (NASDAQ:MXL), selling 1,107,504 shares in a transaction estimated at $17.81 million based on quarterly average pricing. What happened According to a Securities and Exchange Commission (SEC) filing dated February 2, 2026, AIGH Capital Management LLC reported selling all 1,107,504 shares of MaxLinear during the fourth quarter. The estimated transaction value was $17.81 million, based on the average closing price for the pe ...
Why billionaire investor Thomas Kaplan isn't stressing about gold and silver's historic sell-off
Business Insider· 2026-02-02 16:38
Billionaire investor Thomas Kaplan says he's unfazed by the historic plunge in gold and silver prices — and expects the precious metals will rally to even greater highs. There's "every reason in the world to buy gold, and silver is just gold on steroids, up and down," Kaplan told Business Insider on Friday afternoon.Gold and silver soared to record highs last week before falling by around 10% and more than 30%, respectively, on Friday after President Donald Trump nominated Kevin Warsh as the Federal Reserv ...
Gold, silver lower in choppy, volatile trading
KITCO· 2026-02-02 16:38
Jim Wyckoff has spent over 25 years involved with the stock, financial and commodity markets. He was a financial journalist with the FWN newswire service for many years, including stints as a reporter on the rough-and-tumble commodity futures trading floors in Chicago and New York. As a journalist, he has covered every futures market traded in the U.S., at one time or another. Jim is the proprietor of the "Jim Wyckoff on the Markets" analytical, educational and trading advisory service. Jim also worked as a ...
Buy AbbVie Stock Before Q4 Earnings? Here's What to Know
ZACKS· 2026-02-02 16:36
Key Takeaways AbbVie reports Q4 and full-year 2025 earnings Feb. 4, with sales expected above $16.3B and EPS near $2.66.ABBV's newer immunology drugs Skyrizi and Rinvoq are expected to fuel growth as Humira sales keep declining.AbbVie stock trades below industry P/E, driven by a growing pipeline and diversification across franchises.AbbVie (ABBV) is set to report fourth-quarter and full-year 2025 earnings on Feb. 4, before the opening bell. The Zacks Consensus Estimate for the quarter’s sales and earnings i ...
Six More Weeks of Q4 Earnings Season?
ZACKS· 2026-02-02 16:36
Key Takeaways Pre-Markets Start a New Trading Week "Risk Off"Jobs Week Starts Tomorrow with JOLTS, Ending with BLS NumbersQ4 Earnings Season Starts Its Busiest Week So FarMonday, February 2nd, 2026Pre-market futures are trading in the red at this hour, but well up from the early-morning troughs between -1% and the Nasdaq and Russell 2000 -1.75%. Currently, the Dow is down a mere -0.12%, the S&P 500 -0.45%, the Nasdaq -0.71% and the small-cap Russell 2000 -0.38%. We’re still technically “risk off” until furt ...
Nvidia Stock Dips On OpenAI Funding Issues
Investors· 2026-02-02 16:35
Nvidia Stock Dips On OpenAI Funding Issues | Investor's Business DailyBREAKING: [Stocks Swing Higher; Disney, Oracle Are Early Movers]---Nvidia (NVDA) stock dipped Monday on conflicting news reports that the artificial intelligence chipmaker lacked confidence in major customer OpenAI and might have doubts about how much to fund it. The Wall Street Journal reported Friday that Nvidia's plan to invest up to $100 billion in OpenAI to help it train and run AI models had stalled. Nvidia insiders expressed…## Rel ...